Literature DB >> 19022374

The role of reduced pterins in resistance to reactive oxygen and nitrogen intermediates in the protozoan parasite Leishmania.

Wilfried Moreira1, Eric Leblanc, Marc Ouellette.   

Abstract

During its life cycle, the protozoan parasite Leishmania experiences oxidative stress when interacting with macrophages. Reduced pterins are known scavengers of reactive oxygen and nitrogen intermediates. Leishmania has a pteridine reductase, PTR1, whose main function is to provide reduced pterins. We investigated the role of PTR1 in resistance to oxidative and nitrosative stress in Leishmania tarentolae, Leishmania infantum, and Leishmania major PTR1(-/-) mutants. The PTR1(-/-) cells of the three species were more sensitive to H2O2- and NO-induced stress. Using a fluorescent probe allowing ROI quantification, we demonstrated an increase in intracellular oxidant molecules in the PTR1(-/-) mutants. The disruption of PTR1 increased metacyclogenesis in L. infantum and L. major. We purified metacyclic parasites from PTR1(-/-) mutants and control cells and tested their intracellular survival in the J774 mouse cell line and in human monocyte-derived macrophages. Our results showed that PTR1(-/-) null mutants survived less in both macrophage models compared to control cells and this decrease was more pronounced in macrophages activated for oxidant production. This study demonstrates that one physiological role of reduced pterins in Leishmania is to deal with oxidative and nitrosative species, and a decreased ability to provide reduced pterins leads to decreased intracellular survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022374     DOI: 10.1016/j.freeradbiomed.2008.10.034

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  23 in total

1.  Sphingolipid degradation by Leishmania major is required for its resistance to acidic pH in the mammalian host.

Authors:  Wei Xu; Lijun Xin; Lynn Soong; Kai Zhang
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

2.  High affinity S-Adenosylmethionine plasma membrane transporter of Leishmania is a member of the folate biopterin transporter (FBT) family.

Authors:  Larbi Dridi; Amin Ahmed Ouameur; Marc Ouellette
Journal:  J Biol Chem       Date:  2010-04-20       Impact factor: 5.157

Review 3.  State of the art in African trypanosome drug discovery.

Authors:  Robert T Jacobs; Bakela Nare; Margaret A Phillips
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

4.  Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice.

Authors:  Natasha Sienkiewicz; Han B Ong; Alan H Fairlamb
Journal:  Mol Microbiol       Date:  2010-06-01       Impact factor: 3.501

5.  PTR1-dependent synthesis of tetrahydrobiopterin contributes to oxidant susceptibility in the trypanosomatid protozoan parasite Leishmania major.

Authors:  Bakela Nare; Levi A Garraway; Tim J Vickers; Stephen M Beverley
Journal:  Curr Genet       Date:  2009-04-25       Impact factor: 3.886

6.  High-resolution structures of Trypanosoma brucei pteridine reductase ligand complexes inform on the placement of new molecular entities in the active site of a potential drug target.

Authors:  Alice Dawson; Lindsay B Tulloch; Keri L Barrack; William N Hunter
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-11-16

7.  Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum.

Authors:  Arijit Bhattacharya; Philippe Leprohon; Marc Ouellette
Journal:  PLoS Negl Trop Dis       Date:  2021-04-27

8.  Generation of Leishmania hybrids by whole genomic DNA transformation.

Authors:  Adriano C Coelho; Philippe Leprohon; Marc Ouellette
Journal:  PLoS Negl Trop Dis       Date:  2012-09-20

9.  Leishmania major methionine sulfoxide reductase A is required for resistance to oxidative stress and efficient replication in macrophages.

Authors:  Fiona M Sansom; Leonie Tang; Julie E Ralton; Eleanor C Saunders; Thomas Naderer; Malcolm J McConville
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

10.  Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.

Authors:  Lindsay B Tulloch; Viviane P Martini; Jorge Iulek; Judith K Huggan; Jeong Hwan Lee; Colin L Gibson; Terry K Smith; Colin J Suckling; William N Hunter
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.